Adventures in Biotechnology: The Progression of DepoVax from Idea to the Clinic
Immunovaccine Inc. is a clinical-stage biopharmaceutical company dedicated to making immunotherapy more effective, more broadly applicable, and more widely available to people facing cancer and infectious diseases. The company develops cancer immunotherapies and infectious disease vaccines based on the DepoVax platform. On November 9, Marianne Stanford, vice president of research at Immunovaccine, will explore the development of the platform from the preclinical stage through to current clinical development, highlighting the unique challenges of developing new therapies in Atlantic Canada.
Wednesday, November 9, 2016
8:00 am - 9:00 am
Weather Watch Room
5th Floor Dickson Building, VG Site
5820 University Avenue, Halifax